SCHEMBL26745337

SCHEMBL26745337

c1ccc2cc(-c3ncc(-c4nc5cc6cc7sc(-c8cnc(-c9ccc%10ccccc%10c9)s8)nc7cc6cc5s4)s3)ccc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B1 P14061 3/20 0.40
▸ HSD17B2 P37059 3/20 0.40
▸ RAB9A P51151 6/20 0.39
▸ NPC1 O15118 4/20 0.39
▸ MEN1 O00255 3/20 0.39
▸ KMT2A Q03164 3/20 0.39
▸ CYP3A4 P08684 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ APP P05067 4/20 0.38
▸ MAPT P10636 5/20 0.37
▸ PAX8 Q06710 1/20 0.37
▸ NOD2 Q9HC29 1/20 0.37
▸ L3MBTL1 Q9Y468 1/20 0.37
▸ CYP11B1 P15538 2/20 0.36
▸ CYP11B2 P19099 2/20 0.36
▸ CYP17A1 P05093 1/20 0.35
▸ CYP19A1 P11511 1/20 0.35
▸ SMN1; SMN2 Q16637 5/20 0.35
▸ KDM4E B2RXH2 4/20 0.35
▸ ALDH1A1 P00352 3/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26745334 0.86 KDM4E (0.48) HSD17B1HSD17B2RAB9ANPC1MEN1
SCHEMBL26745352 0.85 PDGFRB (0.43) RAB9ANPC1MEN1KMT2AL3MBTL1
SCHEMBL26745036 0.82 APP (0.49) RAB9ANPC1MEN1KMT2AAPP
SCHEMBL26744924 0.82 KDM4E (0.41) RAB9ANPC1MEN1KMT2ACYP2C9
SCHEMBL10013474 0.81 HSD17B1 (0.53) HSD17B1HSD17B2RAB9ANPC1CYP3A4
SCHEMBL10013475 0.81 HSD17B1 (0.53) HSD17B1HSD17B2RAB9ANPC1CYP3A4
SCHEMBL27631112 0.81 HSD17B1 (0.56) HSD17B1HSD17B2RAB9ANPC1CYP3A4
SCHEMBL26745360 0.80 CYP19A1 (0.40) HSD17B1HSD17B2RAB9ANPC1MEN1
SCHEMBL25165769 0.80 HSD17B1 (0.40) HSD17B1HSD17B2RAB9ANPC1CYP3A4
SCHEMBL13142445 0.79 HSD17B1 (0.54) HSD17B1HSD17B2RAB9ANPC1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230345826-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORPORATION (JP) 2023-10-26 — — US disclosed
US-20230345826-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND FUJIFILM CORPORATION (JP) 2023-10-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230345826-A1 PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND TEAD1, CRY1, CPNE4 HSD17B1 4030/4885HSD17B2 4406/4885RAB9A 2451/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback